Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ANTHEM BIOSCIENCES LTD.

NSE : NABSE : 544449ISIN CODE : INE0CZ201020Industry : Pharmaceuticals & DrugsHouse : Private

BSE0.000 (0 %)

PREV CLOSE ( ) NA

OPEN PRICE ( ) 0.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 0

TODAY'S LOW / HIGH ( )0.00 0.00

52 WK LOW / HIGH ( ) 00

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-06 2006

Management Info

Ajay Bhardwaj - Chairman Ajay Bhardwaj - Managing Director

Registered Office

Address No. 49, F1 & F2, Canara Bank Road,Bommasandra Industrial Area,Phase I, Bommasandra,
Bengaluru,
Karnataka-560099

Phone 080-66724000

Email investors.abl@anthembio.com

Website www.anthembio.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

17Jul New Listing
Notice No. 20250718-44 Notice Date 18 Jul 2025Category Company r..

11Jul Anthem Biosciences coming with IPO to
Anthem BiosciencesAnthem Biosciences is coming out with a 100% book buil..

09Apr Anthem Biosciences gets SEBI's approva
Anthem Biosciences has received markets regulator Securities and Exchang..

02Jan Anthem Biosciences files DRHP with SEB
Anthem Biosciences has filed draft red herring prospectus (DRHP) with th..

Financials

Rs. in Millions

	QTR	ANNUAL
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Blue Jet Healthcare (BSE) 1012.00 (4.21%)	M.Cap ( in Cr)17554.70
Jubilant Pharmova (BSE) 1234.90 (2.87%)	M.Cap ( in Cr)19669.63
Mercury Laboratories (BSE) 888.00 (3.71%)	M.Cap ( in Cr)106.56
Sanjivani Paranteral (BSE) 247.40 (11.39%)	M.Cap ( in Cr)301.93
Abbott India (BSE) 34148.85 (0.06%)	M.Cap ( in Cr)72563.92

Shareholding Pattern

	PROMOTERS	76.84%
	NON-INSTITUTION	23.16%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

ANTHEM BIOSCIENCES LTD.